As Poor Nations Seek Covid Pills, Officials Fear Repeat of AIDS Crisis

“Both Merck and Pfizer have reserved for themselves all the high-income countries and virtually all of the upper-middle-income countries and even some lower-middle-income countries,” Professor Brook Baker ’76, policy analyst for Health GAP, tells The New York Times. Professor Baker recently submitted a legal brief in support of the Dominican Republic’s petition to allow the distribution of the generic version of Paxlovid.